Transcutaneous ultrasound applied to the abdomen is a precise method to modulate the cholinergic anti-inflammatory pathway. By targeting the subdiaphragmatic branches of the vagus nerve, this non-invasive approach directly inhibits pro-inflammatory cytokine production within the viscera. While traditional neuromodulation focuses on the cervical vagus nerve, abdominal stimulation provides direct access to the organs where systemic inflammation often originates. Recent clinical data demonstrate that focused ultrasound waves can significantly reduce circulating levels of inflammatory markers like TNF-alpha and IL-6. This technology offers a scalable, non-pharmacological alternative to invasive surgical implants or long-term immunosuppressant therapy. The clinical implications are profound for managing autoimmune conditions, Inflammatory Bowel Disease (IBD), and metabolic disorders driven by chronic inflammation. Precision bioelectronic medicine is shifting from internal hardware to targeted, external acoustic energy to restore systemic homeostasis. https://www.nature.com/articles/s41467-019-08750-9 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5859128/ https://www.skool.com/vagus/major-breakthrough-an-easier-way-to-target-inflammation-effectively-through-abdomen